Aiobio Co (XKRX:447690) Debt-to-Asset : 0.00 (As of . 20)

View and export this data going back to 2022. Start your Free Trial

What is Aiobio Co Debt-to-Asset?

Aiobio Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₩0.00 Mil. Aiobio Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₩0.00 Mil. Aiobio Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in . 20 was ₩0.00 Mil.

Aiobio Co Debt-to-Asset Historical Data

The historical data trend for Aiobio Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aiobio Co Debt-to-Asset Chart

Aiobio Co Annual Data

Trend

Debt-to-Asset

Aiobio Co Semi-Annual Data

Debt-to-Asset

Competitive Comparison of Aiobio Co's Debt-to-Asset

For the Medical Devices subindustry, Aiobio Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aiobio Co's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aiobio Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Aiobio Co's Debt-to-Asset falls into.

Aiobio Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Aiobio Co's Debt-to-Asset for the fiscal year that ended in . 20 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(	+	)	/
	=	N/A

Aiobio Co's Debt-to-Asset for the quarter that ended in . 20 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(	+	)	/
	=	N/A

Aiobio Co (XKRX:447690) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Aiobio Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Aiobio Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Aiobio Co (XKRX:447690) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aiobio Co Ltd (XKRX:447690) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

38, Teheran-ro 4-gil, 8th Floor, Gangnam-gu, Seoul, KOR, 06241

Website

https://www.aiobio.co.kr

Aiobio Co Ltd manufactures products for dental checkup services. Its product includes Qraycam Pro; Qraypen C, W-Block; Qray SW; Qrayview C, Goggles; Qray m and Qscan plus.

Aiobio Co (XKRX:447690) Headlines

No Headlines